138 related articles for article (PubMed ID: 12243822)
21. The impact of postimplant edema on the urethral dose in prostate brachytherapy.
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):661-4. PubMed ID: 10837949
[TBL] [Abstract][Full Text] [Related]
22. Centralized multiinstitutional postimplant analysis for interstitial prostate brachytherapy.
Bice WS; Prestidge BR; Grimm PD; Friedland JL; Feygelman V; Roach M; Prete JJ; Dubois DF; Blasko JC
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):921-7. PubMed ID: 9652858
[TBL] [Abstract][Full Text] [Related]
23. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy.
Crook J; Milosevic M; Catton P; Yeung I; Haycocks T; Tran T; Catton C; McLean M; Panzarella T; Haider MA
Brachytherapy; 2002; 1(2):66-73. PubMed ID: 15062173
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of post-plan dosimetry using TRUS and CT after transperineal prostate seed implant.
Helmick R; Tarver R; Chan R; Caldwell S
Med Dosim; 2002; 27(4):289-93. PubMed ID: 12521076
[TBL] [Abstract][Full Text] [Related]
25. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy.
Tanaka O; Hayashi S; Sakurai K; Matsuo M; Nakano M; Maeda S; Hoshi H; Deguchi T
Radiother Oncol; 2006 Dec; 81(3):303-8. PubMed ID: 17125859
[TBL] [Abstract][Full Text] [Related]
26. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
28. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
D'Souza WD; Thames HD; Kuban DA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
[TBL] [Abstract][Full Text] [Related]
29. Can the Day 0 CT-scan predict the post-implant scanning? Results from 136 prostate cancer patients.
Cattani F; Vavassori A; Comi S; Gherardi F; Russo S; Orecchia R; Jereczek-Fossa BA
Phys Med; 2017 Aug; 40():66-71. PubMed ID: 28743617
[TBL] [Abstract][Full Text] [Related]
30. Comparison of combined x-ray radiography and magnetic resonance (XMR) imaging-versus computed tomography-based dosimetry for the evaluation of permanent prostate brachytherapy implants.
Acher P; Rhode K; Morris S; Gaya A; Miquel M; Popert R; Tham I; Nichol J; McLeish K; Deehan C; Dasgupta P; Beaney R; Keevil SF
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1518-25. PubMed ID: 18513881
[TBL] [Abstract][Full Text] [Related]
31. Source localization following permanent transperineal prostate interstitial brachytherapy using magnetic resonance imaging.
Dubois DF; Prestidge BR; Hotchkiss LA; Bice WS; Prete JJ
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1037-41. PubMed ID: 9392542
[TBL] [Abstract][Full Text] [Related]
32. Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
Merrick GS; Sylvester J; Grimm P; Allen ZA; Butler WM; Reed JL; Khanjian J
Brachytherapy; 2011; 10(1):35-43. PubMed ID: 20153264
[TBL] [Abstract][Full Text] [Related]
33. Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images.
Girum KB; Lalande A; Quivrin M; Bessières I; Pierrat N; Martin E; Cormier L; Petitfils A; Cosset JM; Créhange G
Brachytherapy; 2018; 17(6):866-873. PubMed ID: 30217431
[TBL] [Abstract][Full Text] [Related]
34. Is intraoperative nomogram-based overplanning of prostate implants necessary?
D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
[TBL] [Abstract][Full Text] [Related]
35. Sequential evaluation of prostate edema after permanent seed prostate brachytherapy using CT-MRI fusion.
Taussky D; Austen L; Toi A; Yeung I; Williams T; Pearson S; McLean M; Pond G; Crook J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):974-80. PubMed ID: 15989997
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
Bowes D; Crook JM; Araujo C; Batchelar D
Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
[TBL] [Abstract][Full Text] [Related]
37. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
[TBL] [Abstract][Full Text] [Related]
38. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
[TBL] [Abstract][Full Text] [Related]
39. Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy.
Butler WM; Merrick GS; Dorsey AT; Hagedorn BM
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1575-82. PubMed ID: 11121664
[TBL] [Abstract][Full Text] [Related]
40. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
